Viewing Study NCT02238834


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-02-27 @ 5:10 PM
Study NCT ID: NCT02238834
Status: COMPLETED
Last Update Posted: 2022-08-08
First Post: 2014-09-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers
Sponsor: Foresee Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module